Jerome Salmon obtained a PhD from the Paris VII University in 2003. His research studies at the Pasteur Institute were dedicated to the analysis of the immunogenetic and viral factors controlling the evolution of papillomavirus-associated tumors. He performed his postdoctoral training at the Johns Hopkins University School of Medicine in Baltimore, were he contributed to the large-scale identification of T cell epitopes in NIAID category A-C pathogens for the development of epitope-based vaccines. He later joined the Gustave Roussy Cancer Campus, and explored the immunoregulatory properties of retroviral and filoviral envelope proteins. He is now working on precision medicine for advanced pediatric solid cancers, focusing on the identification of novel tumor antigens and immunosuppressive factors for the development of antibody- and T cell-based therapeutics.